ArticleAntimicrobial agents and chemotherapy2024

Phase 1 drug-drug interaction study to assess the effect of CYP3A4 inhibition and pan-CYP induction on the pharmacokinetics and safety of fosmanogepix in healthy participants.

Michael R Hodges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.